Janney Montgomery Scott
BBIO icon

Janney Montgomery Scott’s BridgeBio Pharma BBIO Stock Holding History

Janney Montgomery Scott’s Portfolio BBIO Stock Details BBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.96M Buy
26,335
+192
+0.7% +$13.4K ﹤0.01% 1501
2026
Q1 		$1.94M Buy
26,143
+528
+2% +$38.3K ﹤0.01% 1297
2025
Q4 		$1.96M Buy
+25,615
New +$1.68M ﹤0.01% 1343

Other funds holding BBIO

JT
Jupiter Topco New York $245B AUM
KKRC
Kohlberg Kravis Roberts & Co New York $5.71B AUM 72.37% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
ACM
Aisling Capital Management New York $472M AUM 106.83% 1-Year Est. Return

Janney Montgomery Scott's BBIO Position: Q2 2026 in Review

Janney Montgomery Scott increased its BridgeBio Pharma (BBIO) stake by 0.73% in Q2 2026, buying an estimated $13.4K and bringing the position to 26,335 shares worth $1.96M. The position accounts for ﹤0.01% of the portfolio, ranked #1501.

Janney Montgomery Scott first reported a position in BBIO in Q4 2025 and has held it in 3 quarters since. 474 funds tracked by Wall St. Rank hold BBIO as of Q2 2026.

  • Janney Montgomery Scott held 26,335 shares of BridgeBio Pharma worth $1.96M as of Q2 2026.
  • Janney Montgomery Scott bought 192 BridgeBio Pharma shares in Q2 2026, an estimated $13.4K.
  • BridgeBio Pharma made up ﹤0.01% of Janney Montgomery Scott's portfolio in Q2 2026, its #1501 holding.
  • Janney Montgomery Scott first reported a position in BridgeBio Pharma in Q4 2025 and has held it in 3 quarters since.
  • 474 funds tracked by Wall St. Rank held BridgeBio Pharma as of Q2 2026.

Based on Janney Montgomery Scott's 13F filing for Q2 2026, filed 5 Aug 2026.